Lv33
210 积分 2024-03-21 加入
Once-weekly insulin efsitora alfa versus once-daily insulin glargine U100 in adults with type 2 diabetes treated with basal and prandial insulin (QWINT-4): a phase 3, randomised, non-inferiority trial
31分钟前
待确认
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
16天前
已完结
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
16天前
已完结
Pamrevlumab for Idiopathic Pulmonary Fibrosis
16天前
已完结
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis
16天前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
26天前
已完结
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
28天前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
29天前
已完结
Ivonescimab in advanced NSCLC: is progression-free survival enough, or are overall survival data also needed?
29天前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
29天前
已完结
皖公网安备34019202002308
